Yosuke Ono

No ORCID on file · 24 papers in corpus · active 2015-2026

Study types

  • article 18
  • other 5
  • book-chapter 1

Condition tags

  • endometriosis 20
  • mesh:D004715 9
  • endometrioma 3
  • adenomyosis 2
  • infertility 1
  • mesh:D004716 1
article 2026
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.70211

PURPOSE: Although studies have suggested a link between gut microbiota and endometriosis pathophysiology, the effects of treatment for endometriosis remain unclear. METHODS: In this prospective observational study, 27 patients with stage II…

other 2026
Experimental animals ·doi:10.1538/expanim.26-0002

Endometriosis, a chronic disease that affects about 10% of women of reproductive age, is characterized by severe pain and growth of endometrium-like tissues outside the uteri. Although several theories have been advanced for the cause of en…

other 2025
Scientific reports ·doi:10.1038/s41598-025-13855-x

The fibrosis mechanism in endometriosis is not elucidated. We investigated the role of eosinophil in fibrosis of endometriosis. The endometriotic stromal cells (ESCs) and endometrial epithelial cells (EECs) were subjected to in vitro experi…

other 2024
RSC chemical biology ·doi:10.1039/d4cb00095a

Human relaxin-2 (H2 relaxin) is a peptide hormone of about 6 kDa, first identified as a reproductive hormone involved in vasoregulation during pregnancy. It has recently attracted strong interest because of its diverse functions, including …

other 2024
Journal of clinical medicine ·doi:10.3390/jcm13164605

Objectives: This prospective study evaluated whether endometriosis is associated with chronic endometritis (CE) and affects the uterine endometrium microbiome (UEM) in women with repeated implantation failure (RIF). Methods: Forty-three wom…

article 2023
Journal of reproductive immunology ·doi:10.1016/j.jri.2023.103955
article 2023
Gynecology and minimally invasive therapy ·doi:10.4103/gmit.gmit_45_22

Objectives: The objective of this study was to observe the influence of laparoscopic adenomyomectomy on perinatal outcomes. Materials and Methods: The retrospective cohort study included 43 pregnant cases with adenomyosis who did not underg…

article 2022
Reproductive medicine and biology ·doi:10.1002/rmb2.12456

Abstract Purpose It is unknown whether surgery for endometriosis or recurrence of endometriosis affects obstetric outcomes. Methods A total of 208 pregnant women with a history of endometriosis were analyzed. Patients who had endometriomas …

article 2021
Scientific reports ·doi:10.1038/s41598-020-79578-3

In endometriosis, M2 MΦs are dominant in endometriotic lesions, but the actual role of M2 MΦ is unclear. CD206 positive (+) MΦ is classified in one of M2 type MΦs and are known to produce cytokines and chemokines. In the present study, we u…

book-chapter 2021
·doi:10.1016/b978-0-12-820661-4.00011-x
article 2021
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2021.102114

INTRODUCTION: Although various perinatal complications have been reported to be increased in the pregnant patients with adenomyosis, it is not clear what type of patients with adenomyosis is more likely to cause obstetric complications. In …

article 2021
·doi:10.1016/j.jri.2021.103391
article 2021
Biomedicines ·doi:10.3390/biomedicines9111519

Sphingosine 1-phosphate (S1P), an inflammatory mediator, is abundantly contained in red blood cells and platelets. We hypothesized that the S1P concentration in the peritoneal cavity would increase especially during the menstrual phase due …

article 2021
·doi:10.3192/jsirib.36.22

子宮内膜症患者では、腹腔内の免疫環境の異常が指摘されている。Macrophage(MΦ)は、腹腔内の主な免疫細胞で、炎症性疾患である子宮内膜症患者の腹腔内においては、抗炎症・免疫抑制性のM2 MΦが優位と報告されているが、なぜM2 MΦ優位なのか、M2 MΦが子宮内膜症の増悪あるいは抑制因子であるのか、その意義は明らかにされていない。我々は逆流月経血中のalarmin IL-33に着目し、IL-33が腹腔内免疫環境をM2 MΦ優位に誘導する因子の1つであることをin vitr…

article 2020
·doi:10.1016/j.jri.2020.103238
other 2020
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-019-00090-9

In endometriosis, M2 macrophages (MΦ) are dominant and promote the development of endometriosis lesions. However, the factor(s) which induces M2 MΦ are unknown. In the present study, we focused on interleukin (IL)-33, known as an alarmin an…

article 2020
Biomedicines ·doi:10.3390/biomedicines8110467

Background: Relaxin (RLX)-2, produced by the corpus luteum and placenta, is known to be potentially effective in fibrotic diseases of the heart, lungs, kidneys, and bladder; however, its effectiveness in endometriosis has not yet been inves…

article 2019
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719119828112
article 2018
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.13702

Endometrioma is known to be an occurrence site of ovarian cancer, but there is no evidence on how to reduce the risk of canceration. Here, we report three cases of ovarian cancer arising from endometrioma during hormone therapies of GnRH an…

article 2017
European journal of pain (London, England) ·doi:10.1002/ejp.1133

BACKGROUND: Endometriosis is a gynaecological disease exhibiting severe pelvic pain, but the mechanism of pain production remains unknown. Bradykinin (BK) is known as an inflammatory mediator, and shows elevated levels in inflammatory disea…

article 2017
·doi:10.1016/j.jri.2017.10.025
article 2016
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.12592

OBJECTIVE: We investigated α-7 nAchR expression in human peritoneal macrophages and examined whether activation of nAchR might be a new therapy for endometriosis. MATERIALS AND METHODS: Human peritoneal fluid mononuclear cells (PFMC) were s…

article 2016
·doi:10.1016/j.jri.2016.10.054
article 2015
·doi:10.1016/j.jri.2015.09.014